New glucocerebrosidase antibodies can advance research in the field of neurodegenerative disorders  

作　　者：Charis Ma Krystyna Rytel Yu Chen Ellen Sidransky 

机构地区：[1]Medical Genetics Branch,National Human Genome Research Institute,National Institutes of Health,Bethesda,MD,USA

出　　处：《Neural Regeneration Research》2025年第4期1085-1086,共2页中国神经再生研究（英文版）

摘　　要：In medical research,there are times when the introduction of a new tool can launch scientific discovery in new directions.While antibody development may be considered mundane,in the field of glucocerebrosidase(GCase)research,the dearth of validated antibodies for different applications has impeded progress in studies of disease pathogenesis and therapeutic development.The recent introduction of new,rigorously evaluated antibodies can now propel research into the link between glucocerebrosidase and Parkinson’s disease(PD)as well as aspects of the pathobiology of Gaucher disease(Jong et al.,2024).

关 键 词：ANTIBODIES cerebro 

分 类 号：R741[医药卫生—神经病学与精神病学]